CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Clarithromycin

克拉霉素 杂质对照品Clarithromycin Impurities

EP34 个杂质条目34 impurity entries

本页汇总 克拉霉素 的 34 个杂质对照品条目,其中药典杂质标注了 EP/USP 编号。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 34 impurity reference standards of Clarithromycin with EP/USP numbering where applicable. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 克拉霉素(Clarithromycin)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 杂质研究Impurity studiesSelecting optimal columns for clarithromycin impurity analysis according to the quantitative relationship of hydrophobic subtraction model
    Journal of pharmaceutical and biomedical analysis · 2017 · Zhang X, Hu C  ·  PMID 28024686  ·  DOI
  2. 杂质研究Impurity studiesFormulation and evaluation of less-painful clarithromycin lipid microspheres
    Archives of pharmacal research · 2007 · LingHao Q, Wei L  ·  PMID 18038913  ·  DOI
  3. 杂质研究Impurity studiesA survey of the quality of generic clarithromycin products from 18 countries
    Clinical drug investigation · 2005 · Nightingale CH  ·  PMID 17523763  ·  DOI

合成路线参考Reported synthetic routes

以下为公开文献中报道的合成方法(题录信息)。标题多已点明关键反应,可据此查阅原文了解完整路线与工艺条件。Published synthetic approaches. Titles usually name the key transformation; consult the original articles for full routes.

  • 合成方法SynthesisA Robust and Scalable Process for the Synthesis of Substantially Pure Clarithromycin 9-(E)-Oxime with an Established Control of the (Z)-Isomer Impurity
    ACS omega · 2023 · Chaudhari K et al.  ·  PMID 36969464  ·  DOI
  • 合成方法SynthesisSynthesis of clarithromycin ketolides chemically modified at the unreactive C10-methyl group
    Bioorganic & medicinal chemistry · 2017 · Anwar HF et al.  ·  PMID 28302508  ·  DOI

克拉霉素 —— 原料药与杂质对照品Clarithromycin — drug substance & impurities

共 35 个条目(含原料药本体)35 items incl. the drug substance
Clarithromycin structure
EP原料药 APIAPI
克拉霉素Clarithromycin
Clarithromycin
CAS No.81103-11-9
Chemical FormulaC38H69NO13
Purity>95%询价On request
10mg25mg50mg100mg
Clarithromycin Impurity 4(Clarithromycin EP Impurity A) structure
EPA
克拉霉素杂质4(克拉霉素EP杂质A)Clarithromycin Impurity 4(Clarithromycin EP Impurity A)
Clarithromycin Impurity 4(Clarithromycin EP Impurity A)
CAS No.124412-58-4
Chemical FormulaC38H69NO14
Purity>95%询价On request
10mg25mg50mg100mg
Clarithromycin Impurity 10(Clarithromycin EP Impurity B) structure
EPB
克拉霉素杂质10(克拉霉素EP杂质B)Clarithromycin Impurity 10(Clarithromycin EP Impurity B)
Clarithromycin Impurity 10(Clarithromycin EP Impurity B)
CAS No.299409-85-1
Chemical FormulaC37H67NO13
Purity>95%询价On request
10mg25mg50mg100mg
Clarithromycin Impurity 3(Clarithromycin EP Impurity C) structure
EPC
克拉霉素杂质3(克拉霉素EP杂质C)Clarithromycin Impurity 3(Clarithromycin EP Impurity C)
Clarithromycin Impurity 3(Clarithromycin EP Impurity C)
CAS No.127253-06-9
Chemical FormulaC38H70N2O13
Purity>95%询价On request
10mg25mg50mg100mg
Clarithromycin Impurity 1 (Clarithromycin EP Impurity D) (N-Desmethyl Clarithromycin) structure
EPD
克拉霉素杂质1 (克拉霉素EP杂质D) (N-去甲基克拉霉素)Clarithromycin Impurity 1 (Clarithromycin EP Impurity D) (N-Desmethyl Clarithromycin)
Clarithromycin Impurity 1 (Clarithromycin EP Impurity D) (N-Desmethyl Clarithromycin)
CAS No.101666-68-6
Chemical FormulaC37H67NO13
Purity>95%询价On request
10mg25mg50mg100mg
Clarithromycin Impurity 5(Clarithromycin EP Impurity E) structure
EPE
克拉霉素杂质5(克拉霉素EP杂质E)Clarithromycin Impurity 5(Clarithromycin EP Impurity E)
Clarithromycin Impurity 5(Clarithromycin EP Impurity E)
CAS No.81103-14-2
Chemical FormulaC39H71NO13
Purity>95%询价On request
10mg25mg50mg100mg
Clarithromycin Impurity 6(Clarithromycin EP Impurity F) structure
EPF
克拉霉素杂质6(克拉霉素EP杂质F)Clarithromycin Impurity 6(Clarithromycin EP Impurity F)
Clarithromycin Impurity 6(Clarithromycin EP Impurity F)
CAS No.128940-83-0
Chemical FormulaC39H71NO13
Purity>95%询价On request
10mg25mg50mg100mg
Clarithromycin Impurity 7(Clarithromycin EP Impurity G) structure
EPG
克拉霉素杂质7(克拉霉素EP杂质G)Clarithromycin Impurity 7(Clarithromycin EP Impurity G)
Clarithromycin Impurity 7(Clarithromycin EP Impurity G)
CAS No.127182-44-9
Chemical FormulaC39H72N2O13
Purity>95%询价On request
10mg25mg50mg100mg
Clarithromycin Impurity 8(Clarithromycin EP Impurity H) structure
EPH
克拉霉素杂质8(克拉霉素EP杂质H)Clarithromycin Impurity 8(Clarithromycin EP Impurity H)
Clarithromycin Impurity 8(Clarithromycin EP Impurity H)
CAS No.127140-69-6
Chemical FormulaC38H67NO14
Purity>95%询价On request
10mg25mg50mg100mg
Clarithromycin Impurity 9(Clarithromycin EP Impurity I) structure
EPI
克拉霉素杂质9(克拉霉素EP杂质I)Clarithromycin Impurity 9(Clarithromycin EP Impurity I)
Clarithromycin Impurity 9(Clarithromycin EP Impurity I)
CAS No.118058-74-5
Chemical FormulaC30H55NO10
Purity>95%询价On request
10mg25mg50mg100mg
Clarithromycin Impurity 11 (Clarithromycin EP Impurity K) structure
EPK
克拉霉素杂质11 (克拉霉素EP杂质K)Clarithromycin Impurity 11 (Clarithromycin EP Impurity K)
Clarithromycin Impurity 11 (Clarithromycin EP Impurity K)
CAS No.130320-81-9
Chemical FormulaC30H51NO8
Purity>95%询价On request
10mg25mg50mg100mg
Clarithromycin Impurity 12(Clarithromycin EP Impurity L) structure
EPL
克拉霉素杂质12(克拉霉素EP杂质L)Clarithromycin Impurity 12(Clarithromycin EP Impurity L)
Clarithromycin Impurity 12(Clarithromycin EP Impurity L)
CAS No.127253-05-8
Chemical FormulaC38H70N2O13
Purity>95%询价On request
10mg25mg50mg100mg
Clarithromycin Impurity 13(Clarithromycin EP Impurity M) structure
EPM
克拉霉素杂质13(克拉霉素EP杂质M)Clarithromycin Impurity 13(Clarithromycin EP Impurity M)
Clarithromycin Impurity 13(Clarithromycin EP Impurity M)
CAS No.127182-43-8
Chemical FormulaC37H68N2O13
Purity>95%询价On request
10mg25mg50mg100mg
Clarithromycin Impurity 14(Clarithromycin EP Impurity N) structure
EPN
克拉霉素杂质14(克拉霉素EP杂质N)Clarithromycin Impurity 14(Clarithromycin EP Impurity N)
Clarithromycin Impurity 14(Clarithromycin EP Impurity N)
CAS No.144604-03-5
Chemical FormulaC38H67NO12
Purity>95%询价On request
10mg25mg50mg100mg
Clarithromycin Impurity 15(Clarithromycin EP Impurity O) structure
EPO
克拉霉素杂质15(克拉霉素EP杂质O)Clarithromycin Impurity 15(Clarithromycin EP Impurity O)
Clarithromycin Impurity 15(Clarithromycin EP Impurity O)
CAS No.127252-80-6
Chemical FormulaC39H72N2O13
Purity>95%询价On request
10mg25mg50mg100mg
Clarithromycin Impurity 16(Clarithromycin EP Impurity P) structure
EPP
克拉霉素杂质16(克拉霉素EP杂质P)Clarithromycin Impurity 16(Clarithromycin EP Impurity P)
Clarithromycin Impurity 16(Clarithromycin EP Impurity P)
CAS No.123967-58-8
Chemical FormulaC39H71NO13
Purity>95%询价On request
10mg25mg50mg100mg
Clarithromycin Impurity 17 structure
17
克拉霉素杂质17Clarithromycin Impurity 17
Clarithromycin Impurity 17
CAS No.118074-07-0
Chemical FormulaC38H69NO14
Purity>95%询价On request
10mg25mg50mg100mg
Clarithromycin Impurity 18 structure
18
克拉霉素杂质18Clarithromycin Impurity 18
Clarithromycin Impurity 18
CAS No.992-62-1
Chemical FormulaC36H65NO13
Purity>95%询价On request
10mg25mg50mg100mg
Clarithromycin Impurity 19 (14S-Hydroxy Clarithromycin) structure
19
克拉霉素杂质19(14S-羟基克拉霉素)Clarithromycin Impurity 19 (14S-Hydroxy Clarithromycin)
Clarithromycin Impurity 19 (14S-Hydroxy Clarithromycin)
CAS No.116836-40-9
Chemical FormulaC38H69NO14
Purity>95%询价On request
10mg25mg50mg100mg
Clarithromycin Impurity 21 structure
21
克拉霉素杂质21Clarithromycin Impurity 21
Clarithromycin Impurity 21
CAS No.18423-89-7
Chemical FormulaC8H16O4
Purity>95%询价On request
10mg25mg50mg100mg
Clarithromycin Impurity 23  (14-Hydroxy Clarithromycin) structure
23
克拉霉素杂质23(14-羟基克拉霉素)Clarithromycin Impurity 23 (14-Hydroxy Clarithromycin)
Clarithromycin Impurity 23 (14-Hydroxy Clarithromycin)
CAS No.110671-78-8
Chemical FormulaC38H69NO14
Purity>95%询价On request
10mg25mg50mg100mg
Clarithromycin Impurity 24 structure
24
克拉霉素杂质24Clarithromycin Impurity 24
Clarithromycin Impurity 24
CAS No.134931-01-4
Chemical FormulaC37H68N2O13
Purity>95%询价On request
10mg25mg50mg100mg
Clarithromycin Impurity 37 structure
37
克拉霉素杂质37Clarithromycin Impurity 37
Clarithromycin Impurity 37
CAS No.1570268-43-7
Chemical FormulaC45H88N2O13Si2
Purity>95%询价On request
10mg25mg50mg100mg
Clarithromycin Impurity 39 structure
39
克拉霉素杂质39Clarithromycin Impurity 39
Clarithromycin Impurity 39
CAS No.119665-62-2
Chemical FormulaC49H96N2O14Si2
Purity>95%询价On request
10mg25mg50mg100mg
Clarithromycin Impurity 40 structure
40
克拉霉素杂质40Clarithromycin Impurity 40
Clarithromycin Impurity 40
CAS No.119665-77-9
Chemical FormulaC42H78N2O14
Purity>95%询价On request
10mg25mg50mg100mg
Clarithromycin Impurity 41 structure
41
克拉霉素杂质41Clarithromycin Impurity 41
Clarithromycin Impurity 41
CAS No.119665-78-0
Chemical FormulaC48H94N2O14Si2
Purity>95%询价On request
10mg25mg50mg100mg
Clarithromycin Impurity 42 structure
42
克拉霉素杂质42Clarithromycin Impurity 42
Clarithromycin Impurity 42
CAS No.2100299-95-2
Chemical FormulaC45H86N2O14Si
Purity>95%询价On request
10mg25mg50mg100mg
Clarithromycin Impurity 43 structure
43
克拉霉素杂质43Clarithromycin Impurity 43
Clarithromycin Impurity 43
CAS No.470-12-2
Chemical FormulaC8H16O4
Purity>95%询价On request
10mg25mg50mg100mg
Clarithromycin Impurity 44 structure
44
克拉霉素杂质44Clarithromycin Impurity 44
Clarithromycin Impurity 44
CAS No.1030374-65-2
Chemical FormulaC57H85N3O12
Purity>95%询价On request
10mg25mg50mg100mg
Clarithromycin Impurity 45 ((14R)-Hydroxy Clarithromycin) structure
45
克拉霉素杂质45 ((14R)-羟基克拉霉素)Clarithromycin Impurity 45 ((14R)-Hydroxy Clarithromycin)
Clarithromycin Impurity 45 ((14R)-Hydroxy Clarithromycin)
CAS No.116836-41-0
Chemical FormulaC38H69NO14
Purity>95%询价On request
10mg25mg50mg100mg
Clarithromycin Impurity 47 structure
47
克拉霉素杂质47Clarithromycin Impurity 47
Clarithromycin Impurity 47
CAS No.130320-82-0
Chemical FormulaC30H51NO8
Purity>95%询价On request
10mg25mg50mg100mg
Clarithromycin Impurity 48 structure
48
克拉霉素杂质48Clarithromycin Impurity 48
Clarithromycin Impurity 48
CAS No.119699-81-9
Chemical FormulaC48H94N2O14Si2
Purity>95%询价On request
10mg25mg50mg100mg
Clarithromycin Impurity 50 structure
50
克拉霉素杂质50Clarithromycin Impurity 50
Clarithromycin Impurity 50
CAS No.129317-09-5
Chemical FormulaC52H100N2O14Si2
Purity>95%询价On request
10mg25mg50mg100mg
Clarithromycin Impurity 51 structure
51
克拉霉素杂质51Clarithromycin Impurity 51
Clarithromycin Impurity 51
CAS No.129317-10-8
Chemical FormulaC53H102N2O14Si2
Purity>95%询价On request
10mg25mg50mg100mg
Clarithromycin Impurity 52 structure
52
克拉霉素杂质52Clarithromycin Impurity 52
Clarithromycin Impurity 52
CAS No.119665-76-8
Chemical FormulaC47H92N2O14Si2
Purity>95%询价On request
10mg25mg50mg100mg

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

克拉霉素 —— 研究文献与合成路线Clarithromycin — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 克拉霉素 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Clarithromycin. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. Interplay of degradation, dissolution and stabilization of clarithromycin and its amorphous solid dispersions
    Pereira JM, Mejia-Ariza R, Ilevbare GA, et al. · Molecular pharmaceutics · 2013 · 被引 36cited 36
  2. Acid-catalyzed degradation of clarithromycin and erythromycin B: a comparative study using NMR spectroscopy
    Mordi MN, Pelta MD, Boote V, et al. · Journal of medicinal chemistry · 2000 · 被引 26cited 26
  3. Selecting optimal columns for clarithromycin impurity analysis according to the quantitative relationship of hydrophobic subtraction model
    Zhang X, Hu C · Journal of pharmaceutical and biomedical analysis · 2017 · 被引 3cited 3
  4. A Robust and Scalable Process for the Synthesis of Substantially Pure Clarithromycin 9-(E)-Oxime with an Established Control of the (Z)-Isomer Impurity
    Chaudhari K, Gohar A, Claerhout S, et al. · ACS omega · 2023 · 被引 1cited 1
  5. Development and Validation of Multiplex Quantitative PCR Assay for Detection of Helicobacter pylori and Mutations Conferring Resistance to Clarithromycin and Levofloxacin in Gastric Biopsy
    Binmaeil H, Hanafiah A, Mohamed Rose I, et al. · Infection and drug resistance · 2021 · 被引 20cited 20
  6. Rapid detection of clarithromycin resistance in Helicobacter pylori using a PCR-based denaturing HPLC assay
    Posteraro P, Branca G, Sanguinetti M, et al. · The Journal of antimicrobial chemotherapy · 2006 · 被引 16cited 16

合成与制备工艺专利Synthesis & process patents

  1. A PROCESS FOR PREPARING CLARITHROMYCIN AND CLARITHROMYCIN INTERMEDIATE
    GUPTE Rajan Vitthal, HIRE Chandrabhan Madhav, SABADE Kishore Balaji · 公开号 WO2007029265WO2007029265 · 2007
  2. METHOD OF PREPARING CLARITHROMYCIN
    RAO XINTANG, DING ZHIJIAN, LOU HANGBIN, WU JING, et al. · 公开号 US2010280230US2010280230 · 2010
  3. PROCESS FOR THE PREPARATION OF CLARITHROMYCIN
    BOSCH Immaculada, CENTELLAS Victor, ROMERO Sandra · 公开号 WO2005090377WO2005090377 · 2005
  4. PROCESS FOR THE PREPARATION OF CLARITHROMYCIN
    BOSCH Immaculada, CENTELLAS Victor, ROMERO Sandra · 公开号 EP1727824EP1727824 · 2006
  5. Processes for preparing clarithromycin polymorphs
    MASARWA BASEM, SCHWARTZ EDI, AVRUTOV ILYA, LIFSHITZ IGOR · 公开号 AU2005203314AU2005203314 · 2005

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

克拉霉素 杂质谱研究要点Clarithromycin — impurity profiling notes

下面这些是拿到 克拉霉素 的 35 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 35 impurity entries for Clarithromycin, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

本品种含药典编号杂质(EP/USP)。申报时药典已收载的杂质通常需要逐项对照,建议优先备齐药典编号对照品,再补充工艺与降解杂质。This drug substance includes pharmacopoeially designated impurities (EP/USP). Monographed impurities normally need item-by-item comparison during filing, so secure the pharmacopoeial standards first, then fill in process and degradation impurities.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances